Back to search

University of West Attica

Αναπνευστικοί ιοί σε ασθενείς με Χρόνια Αποφρακτική Πνευμονοπάθεια (ΧΑΠ): συστηματική ανασκόπηση μοριακών μεθόδων ανίχνευσης και μετα-ανάλυση επιπολασμού και κλινικών επιπτώσεων

Abstract

dc:description

Background: Chronic Obstructive Pulmonary Disease (COPD) is a major global health burden, characterized by persistent airflow limitation and chronic respiratory symptoms such as dyspnea, cough, and sputum production. It ranks among the top three causes of mortality worldwide and is associated with substantial morbidity, impaired quality of life, and high healthcare costs. A defining feature of COPD is the occurrence of acute exacerbations (AECOPD), which are episodes of sudden clinical deterioration requiring hospitalization or treatment modification. Mounting evidence highlights respiratory viruses as key etiological agents in the pathogenesis of AECOPD, either as primary triggers or as facilitators of secondary bacterial infections. Viruses such as rhinovirus, influenza, respiratory syncytial virus (RSV), and coronaviruses are frequently implicated. The increasing availability of molecular diagnostic tools, especially polymerase chain reaction (PCR)-based assays, has significantly improved our ability to detect viral pathogens in both exacerbation and stable phases of the disease. Nonetheless, there remains substantial heterogeneity in the reported prevalence rates and the clinical consequences of viral detection, reflecting variations in study designs, sample types, detection techniques, and population characteristics. A comprehensive synthesis of the current evidence is therefore essential to better understand the role of viral infections in COPD, inform clinical decision-making, and guide the development of targeted preventive and therapeutic strategies. Objective: This systematic review and meta-analysis aimed to assess the pooled prevalence of respiratory viruses in COPD patients, as detected by molecular methods and to examine the associated clinical outcomes during both exacerbation and stable phases. Methods: This meta-analysis was conducted in accordance with the Cochrane Collaboration methodology and the PRISMA guidelines. A systematic search of published studies was performed in four databases, until recently, using controlled vocabulary terms without language restrictions. The study protocol was pre-registered in PROSPERO and published in BMJ Open. Eligible studies were required to utilize molecular detection techniques for the identification of respiratory viruses in adult populations with a confirmed diagnosis of COPD. Studies focusing on high-risk populations for infections or conducted during the COVID-19 pandemic period were excluded. Data extraction, regarding study and participant characteristics was conducted independently by two reviewers using a standardized data collection form. The methodological quality of the included studies was assessed using the risk of bias tool developed by Hoy et al. (2012). Random-effects meta-analyses were performed to account for anticipated heterogeneity across studies, and pooled prevalence estimates with 95% confidence intervals (CIs) were calculated. Subgroup analyses were performed to compare viral prevalence between exacerbation versus stable COPD phases, exacerbation severity levels, sample types (upper vs. lower respiratory tract) and virus types (e.g., rhinovirus, influenza, RSV, coronavirus). Heterogeneity was assessed using the I² statistic, with values >50% indicating substantial heterogeneity. Sensitivity analyses were performed to evaluate the impact of low-quality studies and publication bias was assessed using funnel plots. Finally, potential sources of heterogeneity in the primary meta-analyses were explored through univariable and multivariable meta-regression analyses.Results: Out of 11,894 titles screened, a total of 93 eligible studies were identified. The pooled prevalence of respiratory viruses during the stable phase of COPD was estimated at 10.18% (95% CI: 6.92%, 13.99%), based on data from 17 studies comprising 3,380 participants. Among stable patients, the most frequently detected viruses were rhinovirus (4.25%, 95% CI: 2.8%, 6%), respiratory syncytial virus (RSV) (3.67%, 95% CI: 1.26%, 7.27%), and influenza virus (1.43%, 95% CI: 0.50%, 2.83%). In contrast, during exacerbations, the pooled prevalence of respiratory viruses was significantly higher at 36.57% (95% CI: 33.58%, 39.60%), derived from 60 studies involving 8,442 participants. Rhinovirus remained the most prevalent (12.22%, 95% CI: 10.14%, 14.46%), followed by influenza virus (7.96%, 95% CI: 4.80%, 11.83%) and RSV (5.29%, 95% CI: 3.92%, 6.87%). Virus detection was more common in moderate (44.07%, 95% CI: 37.66%, 50.59%) than in severe exacerbations (36.21%, 95% CI: 31.12%, 41.46%), although this difference did not reach statistical significance (p = 0.07). Sampling method significantly influenced virus detection rates. During exacerbations, the prevalence of any respiratory virus was higher in lower respiratory tract samples (39.64%, 95% CI: 34.81%, 44.58%) compared to upper respiratory tract samples (32.61%, 95% CI: 28.56%, 36.80%) (group difference = 0.04). This was primarily attributed to a significantly higher prevalence of rhinovirus in lower tract samples (18.42% vs. 9.02%, p<0.001) as well as adenovirus (2.05% vs. 0.57%, p = 0.004). Among stable patients, virus prevalence did not differ significantly by sample type, though numerically it was higher in upper airway specimens (11.58% vs. 6.33%).The most commonly used method for respiratory virus detection in the included studies was qualitative PCR (58%), followed by real-time PCR (49.5%), while 16.1% of the studies utilized advanced analytical technologies such as microarrays, bio-chips, microspheres, and biosensors. The mNGS method was employed in 1% of the studies, while 5 out of 93 studies did not provide clear information regarding the type of PCR method they used. The majority of the studies (56.9%) used multiplex virus detection protocols. Finally, in two-thirds of the studies, in-house protocols were preferred over commercially available ones. Substantial heterogeneity was observed across most meta-analyses and was not resolved through univariable meta-regressions. In multivariable analyses, heterogeneity in stable COPD was partially explained by spirometric severity and inhaled corticosteroid use, while in exacerbation studies, it was largely accounted for by spirometric severity, influenza vaccination status in the prior year, ICS use, and sample type. Notably, heterogeneity in subgroup analyses based on sample site was minimized when FEV₁, ICS use, and influenza vaccination were considered. All funnel plots, except for that of the influenza virus, were symmetrical, indicating a low risk of publication bias. Conclusions: Respiratory viruses, particularly rhinovirus, influenza, and RSV, are frequently detected during COPD exacerbations and are associated with worse clinical outcomes. These findings underscore the need for targeted clinical interventions, such as vaccinations and antiviral therapies, to reduce the frequency and severity of exacerbations. They also highlight the importance of systematically using standardized molecular techniques in the assessment of COPD exacerbations.

Degree

thesis:*
Grantor dc:publisher
University of West Attica
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kefala, Anastasia-Maria
  • Κεφάλα, Αναστασία-Μαρία

Subjects

dc:subject × 26

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60553

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kefala, Anastasia-Maria; Κεφάλα, Αναστασία-Μαρία. Αναπνευστικοί ιοί σε ασθενείς με Χρόνια Αποφρακτική Πνευμονοπάθεια (ΧΑΠ): συστηματική ανασκόπηση μοριακών μεθόδων ανίχνευσης και μετα-ανάλυση επιπολασμού και κλινικών επιπτώσεων. University of West Attica, 2025. http://hdl.handle.net/10442/hedi/60553